- Investing Ideas
- Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
3
0 new
Mid-Large Cap Stocks
3 companies
Financière de Tubize
Market Cap: €9.2b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€212.00
7D
7.9%
1Y
71.2%
UCB
Market Cap: €46.1b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€244.60
7D
6.4%
1Y
55.4%
argenx
Market Cap: €43.6b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€705.80
7D
4.5%
1Y
35.6%